December 2018

Scientific Journal/Case Study

Our two latest editions of The Altascientist focus on biosimilars and metabolic disorders, namely Diabetes and Nonalcoholic Fatty Liver Disease (NAFLD). Learn more about our case study, key considerations for sponsors before starting their biosimilar trials, and much more.

Bioanalytical Corner

View our latest assay list, access our scientific posters presented at AAPS and view our most recent bioanalytical webinar on demand.

Industry News

Get an exclusive first look at our newly expanded ligand binding bioanalytical laboratory.

Recent Innovations in Microsampling

Our experts weigh in on the latest evolution in Microsampling that is changing the landscape of low‑volume blood collection by offering a novel approach to patient-centric sampling.

Press Room

Altasciences completes acquisition of preclinical testing business and hires key staff to support the preclinical and clinical markets. Check out all our latest news releases!

» ACCESS FULL NEWSLETTER

If you wish to unsubscribe from our email communications,
please click here.